... and innovative cancer therapies. Building on over half a century of leading and groundbreaking Canadian stem cell research, the company is supported by established links to a group of prominent Toronto academic research institutes and cancer ...
http://www.marketwired.com/press-release/stem-cell-therapeutics-receives-us-orphan-drug-designation-use-tigecycline-treat-acute-tsx-venture-sss-1846881.htm
http://www.marketwired.com/press-release/stem-cell-therapeutics-receives-us-orphan-drug-designation-use-tigecycline-treat-acute-tsx-venture-sss-1846881.htm
No comments:
Post a Comment